Clinical Research Currents
  • Home
  • About Us
  • News
    • AI & Machine Learning
    • Alzheimers & Dementia
    • Animal studies
    • Clinical development
    • Clinical science
    • Contract Research Organization
    • Disparities
    • Education
    • Employment
    • FDA
    • FDA Guidance
    • FDA Guidance Documents
    • History
    • Immunotherapy
    • Innovation
    • International
    • Interview
    • Investigator
    • Mobile
    • NIH
    • Operations
    • Patient Perspective
    • Political economy
    • Pre-clinical
    • Precision Medicine
    • Recruitment
    • Regulatory
    • Study Design
    • Wearables
    • Trends
    • Real World Data/Evidence
    • Blockchain
    • Clinical trials
    • Adverse events
    • Technology
  • Calendar
  • Newsletter
  • Resources

2021 Update

Clinical Research Currents has temporarily suspended publication.
Learn about our new clinical trials startup, Sparrow Search, connecting patients with clinical trials.

FDA to hold public meeting on complex innovative study designs (CID) to inform guidance

www.raps.org

February 26, 2018
Clinical science, FDA

The FDA will hold a public meeting on March 20 to discuss the use of complex innovative designs (CID) in clinical trials of drugs and biological products to inform regulatory decision making. The meeting is intended to help the FDA develop a guidance document on CID, as required by the 21st Century Cures Act, and develop a CID pilot program.  To register for this meeting, visit: https://complexinnovativedesigns.eventbrite.com/  (Regulatory Focus)

IBM Watson, CDC hunting for new blockchain applications for healthcare

www.healthcareitnews.com

October 31, 2017
AI & Machine Learning, Clinical development, FDA

The Centers for Disease Control and Prevention (CDCP) has signed on with IBM Watson Health to explore new applications for blockchain in healthcare. IBM says this is an expansion of its existing work with the U.S. FDA, which is exploring potential blockchain applications for EHRs, clinical trials, internet-of-things, genomics and more.  Blockchain technology offers a high level of security, and when combined with AI holds big promise for managing patient data. (HealthcareITNews)

FDA considers setting up a new “Office of Patient Affairs”

www.raps.org

March 19, 2017
FDA, FDA Guidance, Patient Perspective

As part of its efforts to capture patients’ perspectives, the U.S. FDA is considering establishing an “Office of Patient Affairs” that would be tasked with coordinating patient engagement across the agency. The move to create the office would be part of the agency’s efforts to offer a single entry point to the Agency for the patient community and patient stakeholders.  (Regulatory Focus)

Current Feature

Welcome freelance writer Madison Arenchild!

February 1, 2017
Life sciences, News

Madison Arenchild, who relocated to San Diego in October 2016, is a freelance writer for Clinical Research Currents. Madison graduated from UCLA in the department of The Institute for Society and Genetics in 2016, where she studied developmental biology and public health. She also works in digital marketing, and spends her time Read more

Subscribe to our Newsletter

Get the latest clinical research news delivered straight to your inbox each week.

Submit a Story

Do you have a story you'd like to feature on our website? Share it with us today!

Submit your story

 Join our LinkedIn Group

© 2021 Clinical Research Currents · All Rights Reserved